ERAL1 and cancer: ThehERα pre-mRNA is known to be alternatively splicedresulting in hERα variants that confer dominant-positive and dominant-negative effectson the protein functions (50), and thesevariants are hypothesized to contribute to progression of certain cancers (51–54).